Employment Support After Hematopoietic Stem Cell Transplantation

Description

This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.

Conditions

Hematopoietic Stem Cell Transplantation

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.

Supportive Care Intervention Development to Address Employment Concerns After Allogeneic Hematopoietic Stem Cell Transplantation

Employment Support After Hematopoietic Stem Cell Transplantation

Condition
Hematopoietic Stem Cell Transplantation
Intervention / Treatment

-

Contacts and Locations

Boston

MGH Cancer Center, Boston, Massachusetts, United States, 02114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Received an allogeneic HSCT within the past six months to treat a hematological malignancy.
  • * Screen positive for work-related concerns (i.e., responds "yes" to the question, "Are you concerned about your ability to return to work in the coming six months?")
  • * Patients with acute psychiatric or cognitive conditions which the treating clinician believes prohibits informed consent or compliance with the study procedures
  • * We will not enroll the following special populations: adults unable to consent, individuals not yet adults, pregnant women, and prisoners.

Ages Eligible for Study

18 Years to 70 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

MGH Institute of Health Professions,

Kathleen Lyons, ScD, OTR/L, PRINCIPAL_INVESTIGATOR, MGH Institute of Health Professions

Study Record Dates

2025-12-31